Irska - angleščina - HPRA (Health Products Regulatory Authority)

sanofi pasteur - hepatitis a virus - suspension for injection in pre-filled syringe - 160 d-ant. percent volume/volume - hepatitis vaccines; hepatitis a, inactivated, whole virus

Irska - angleščina - HPRA (Health Products Regulatory Authority)

sanofi pasteur - salmonella typhi, vi antigen - solution for injection - 25/0.5 microgram(s) - typhoid, purified polysaccharide antigen

Velika Britanija - angleščina - MHRA (Medicines & Healthcare Products Regulatory Agency)

sanofi pasteur - rabies virus inactivated - powder and solvent for suspension for injection

Irska - angleščina - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - pneumococcal polysaccharide serotype 1, pneumococcal polysaccharide type 2 (2), pneumococcal polysaccharide type 3 (3), pneumococcal polysaccharide serotype 4, pneumococcal polysaccharide serotype 5, pneumococcal polysaccharide serotype 6b, pneumococcal polysaccharide serotype 7f, pneumococcal polysaccharide type 8 (8), pneumococcal polysaccharide type 9n, pneumococcal polysaccharide serotype 9v, pneumococcal polysaccharide type 20 (20), pneumococcal oligosaccharide serotype 18c, pneumococcal polysaccharide - solution for injection in pre-filled syringe - 25/0.5 microgram/ml - pneumococcal vaccines - it is recommended for active immunisation against disease caused by the pneumococcal serotypes included in the vaccine

Malta - angleščina - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - pertactin, pertussis toxoid, diphtheria toxoid, filamentous haemagglutinin, fha, fimbriae types, and, tetanus toxoid - suspension for injection - pertactin 3 µg pertussis toxoid 2.5 µg diphtheria toxoid filamentous haemagglutinin (fha) 5 µg fimbriae types 2 and 3 5 µg tetanus toxoid - vaccines

Združene države Amerike - angleščina - NLM (National Library of Medicine)

sanofi pasteur inc. - influenza a virus a/california/7/2009(h1n1)-like antigen (formaldehyde inactivated) (unii: 5i5hvc73i8) (influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (formaldehyde inactivated) - unii:euj84un96z) - influenza a virus a/california/7/2009(h1n1)-like hemagglutinin antigen (formaldehyde inactivated) 15 ug in 0.5 ml - influenza a (h1n1) 2009 monovalent vaccine is an inactivated influenza virus vaccine indicated for active immunization of persons 6 months of age and older against influenza disease caused by pandemic (h1n1) 2009 virus. do not administer influenza a (h1n1) 2009 monovalent vaccine to anyone with a known severe hypersensitivity to egg proteins or any component of the vaccine or life-threatening reactions after previous administration of any influenza vaccine. [see warnings and precautions (5) and description (11) ] sanofi pasteur's influenza a (h1n1) 2009 monovalent vaccine and seasonal trivalent influenza virus vaccine (fluzone vaccine) are manufactured by the same process. available information for fluzone vaccine is provided in this section. pregnancy category c: animal reproduction studies have not been conducted with influenza a (h1n1) 2009 monovalent vaccine or fluzone vaccine. it is also not known whether these vaccines can cause fetal harm when administered to a pregnant woman or can affect reproduction

Irska - angleščina - HPRA (Health Products Regulatory Authority)

sanofi pasteur - yellow fever virus 17 d-204 strain - powder and solvent for suspension for injection in pre-filled syringe - 1000 international unit(s) - yellow fever vaccines; yellow fever, live attenuated

Malta - angleščina - Medicines Authority

sanofi pasteur 14 espace henry vallée , 69007 lyon, france - poliovirus, inactivated, type, mahoney strain, mef, saukett strain - suspension for injection - poliovirus (inactivated) type 1 (mahoney strain) 40 dagu poliovirus (inactivated) type 2 (mef-1 strain) 8 dagu poliovirus (inactivated) type 3 (saukett strain) 32 dagu - vaccines

Irska - angleščina - HPRA (Health Products Regulatory Authority)

sanofi pasteur - purified tetanus toxoid; purified diphtheria toxoid ph. eur.; adsorbed purified pertussis toxoid; adsorbed purified filamentous haemagglutinin; inactivated poliomyelitis virus ph. eur; inactivated type 1 poliovirus; inactivated type 2 poliovirus; inactivated type 3 poliovirus - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - bacterial and viral vaccines, combined; diphtheria-pertussis-poliomyelitis-tetanus

Irska - angleščina - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - yellow fever virus 17 d-204 strain - suspension for injection - 1000 - yellow fever vaccines